Clinical Trials Browser

Essential Hypertension × Endocrine × Clear all

NCT01022515 2026-02-06

PHEO

Phase NA Completed

Essential Hypertension, Hypertension, Paraganglioma, Pheochromocytoma

NCT06090617 2024-03-19

WHYSKI

Essential Hypertension, Hyperaldosteronism, Hypertension, Adrenocortical Adenoma

NCT01629225 2014-11-18

GRK4 Polymorphisms Blood Pressure Response to Candesartan

Phase 4 Unknown

Essential Hypertension, Multiple Endocrine Neoplasia Type 1